2027年癌症免疫治疗市场预计将大幅增长,因为癌症流行率和对定向治疗的需求上升。 2027 cancer immunotherapy market expected to grow significantly due to rising cancer prevalence and demand for targeted therapies.
com的一份报告详述了癌症免疫疗法的迅速演变,突出说明了利用免疫系统的治疗方法,如CAR-T细胞和检查站抑制器。 A report from ResearchAndMarkets.com details the rapid evolution of cancer immunotherapy, highlighting treatments that leverage the immune system, such as CAR-T cells and checkpoint inhibitors. 这一市场价值数十亿美元,预计到2027年将大幅增长,其驱动因素是癌症发病率和对定向治疗的需求不断上升。 The market, valued in billions, is expected to grow significantly by 2027, driven by rising cancer prevalence and demand for targeted therapies. 此外,Aethlon Medical公司在癌症患者中试用其血净化器装置时获得了道德认可,这标志着创新治疗方案向前迈出了一步。 Additionally, Aethlon Medical has received ethics approval for a trial of its Hemopurifier® device in cancer patients, marking a step forward in innovative treatment options.